NCT02015507	clinical trial	20140201	An Open-Label, Phase 1 Study in Healthy Adult Subjects to Examine the Effects of Multiple-Dose Ciprofloxacin on Ivacaftor and VX-661 in Combination With Ivacaftor
NCT00457821	clinical trial	20080801	Safety Study of Ivacaftor in Subjects With Cystic Fibrosis
NCT01768663	clinical trial	20130901	A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult Subjects
NCT01060566	clinical trial	20100301	Study of VX-770 on Midazolam and Rosiglitazone and the Effect of Fluconazole on VX-770
NCT01705145	clinical trial	20140301	Study of Ivacaftor in Cystic Fibrosis Subjects 2 Through 5 Years of Age With a CTFR Gating Mutation
NCT01807923	clinical trial	20140401	A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation (TRAFFIC)
NCT01807949	clinical trial	20140401	A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation (TRANSPORT)
NCT01899105	clinical trial	20130801	A Phase 1 Study to Investigate the Food Effect of Lumacaftor in Combination With Ivacaftor
NCT01614457	clinical trial	20131001	Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have the R117H-CFTR Mutation (KONDUCT)
NCT01614470	clinical trial	20131001	Study of Ivacaftor in Subjects With Cystic Fibrosis Who Have a Non-G551D CFTR Gating Mutation (KONNECTION)
NCT01531673	clinical trial	20140301	Study of VX-661 Alone and in Combination With Ivacaftor in Subjects Homozygous or Heterozygous to the F508del-Cystic Fibrosis Transmembrane Conductance Regulator(CFTR) Mutation
NCT00909532	clinical trial	20100701	Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D Mutation (STRIVE)
NCT00909727	clinical trial	20101101	Study of Ivacaftor in Cystic Fibrosis Subjects Aged 6 to 11 Years With the G551D Mutation (ENVISION)
NCT00953706	clinical trial	20100701	Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Homozygous for the F508del-CFTR Mutation (DISCOVER)
NCT01888393	clinical trial	20131101	Study of Lumacaftor in Combination With Ivacaftor in Subjects With Moderate Hepatic Impairment and Healthy Subjects
NCT01216046	clinical trial	20110501	Drug-Drug Interaction Study of VX-770 and VX-809 in Healthy Subjects
NCT01018368	clinical trial	20100301	Study of VX-770 and Rifampin in Healthy Male Subjects
NCT00966602	clinical trial	20091201	Drug-Drug Interaction Study of VX-809 and VX-770 in Healthy Subjects
NCT01153542	clinical trial	20100801	Study of VX-770 on Desipramine
NCT01262352	clinical trial	20111101	Study of the Effect of Ivacaftor on Lung Clearance Index in Subjects With Cystic Fibrosis and the G551D Mutation
NCT01208285	clinical trial	20101201	Study of VX-770 in Subjects With Moderate Hepatic Impairment and in Matched Healthy Subjects
